Carret Asset Management’s Medtronic MDT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$278K Buy
+3,551
New +$286K 0.02% 265
2023
Q2
Sell
-2,601
Closed -$210K 275
2023
Q1
$210K Hold
2,601
0.03% 247
2022
Q4
$202K Sell
2,601
-650
-20% -$52.7K 0.03% 261
2022
Q3
$263K Sell
3,251
-88
-3% -$7.91K 0.04% 225
2022
Q2
$300K Buy
3,339
+30
+0.9% +$3.04K 0.04% 220
2022
Q1
$367K Hold
3,309
0.04% 220
2021
Q4
$342K Hold
3,309
0.04% 225
2021
Q3
$415K Sell
3,309
-174
-5% -$22.5K 0.05% 209
2021
Q2
$432K Hold
3,483
0.05% 206
2021
Q1
$411K Hold
3,483
0.05% 200
2020
Q4
$408K Buy
+3,483
New +$383K 0.05% 193
2014
Q3
Sell
-22,064
Closed -$1.41M 274
2014
Q2
$1.41M Sell
22,064
-970
-4% -$58.9K 0.27% 93
2014
Q1
$1.42M Sell
23,034
-50
-0.2% -$2.91K 0.28% 89
2013
Q4
$1.32M Sell
23,084
-882
-4% -$50K 0.27% 96
2013
Q3
$1.28M Sell
23,966
-1,550
-6% -$83.4K 0.28% 93
2013
Q2
$1.31M Buy
+25,516
New +$1.26M 0.27% 90

Other funds holding MDT

Carret Asset Management's MDT Position: Q2 2026 in Review

Carret Asset Management opened a new position in Medtronic (MDT) in Q2 2026: 3,551 shares worth $278K. The stake represents 0.02% of the portfolio and ranks #265 among its holdings. This is a return to the name: Carret Asset Management previously reported a position in MDT as recently as Q1 2023.

Carret Asset Management first reported a position in MDT in Q2 2013 and has held it in 16 quarters since. The position peaked at $1.42M in Q1 2014. 2,135 funds tracked by Wall St. Rank hold MDT as of Q2 2026.

  • Carret Asset Management held 3,551 shares of Medtronic worth $278K as of Q2 2026.
  • Medtronic was a new Carret Asset Management position in Q2 2026.
  • Medtronic made up 0.02% of Carret Asset Management's portfolio in Q2 2026, its #265 holding.
  • Carret Asset Management first reported a position in Medtronic in Q2 2013 and has held it in 16 quarters since.
  • Carret Asset Management's Medtronic position peaked at $1.42M in Q1 2014.
  • 2,135 funds tracked by Wall St. Rank held Medtronic as of Q2 2026.

Based on Carret Asset Management's 13F filing for Q2 2026, filed 4 Aug 2026.